Home Newsfeeds Citigroup Maintains Neutral on Rocket Companies, Raises Price Target to $8

Citigroup Maintains Neutral on Rocket Companies, Raises Price Target to $8

Citigroup analyst Arren Cyganovich maintains Rocket Companies (NYSE:RKT) with a Neutral and raises the price target from $7 to $8.

byBenzinga Newsdesk

March 1, 2023

1 minute read

Citigroup analyst Arren Cyganovich maintains Rocket Companies (NYSE:RKT) with a Neutral and raises the price target from $7 to $8.

Frequency Electronics, Inc. Names Tom McClelland As Permanent President And CEO

By Benzinga Newsdesk

January 17, 10:23 AM

Frequency Electronics, Inc. ("FEI" or the "Company") (NASDAQ-FEIM) is pleased to announce today that Tom McClelland will have the interim title removed and will serve as the Company's President

FEIM

Short Seller Bear Cave Hits ODDITY Tech With Bear Report – What’s Going On?

By Lekha Gupta

September 7, 11:25 AM

Short Seller Bear Cave reporter Edwin Dorsey furnished a short report on ODDITY Tech Ltd (NASDAQ: ODD), citing the company's business as 'high on hype,

ODD

Analyst Ratings

Where Mineralys Therapeutics Stands With Analysts

By Benzinga Insights

May 16, 2:02 PM

Over the past 3 months, 7 analysts have published their opinion on Mineralys Therapeutics (NASDAQ:MLYS) stock. These analysts…

MLYS

Small Pharma Implements Cost-Cutting Strategy To Reduce Cash Burn As Trial Progresses

By Lara Goldstein

June 29, 2:55 PM

UK-based biotech firm Small Pharma Inc. (OTCQB: DMTTF) shared its financial outcomes for the fiscal year ended Feb. 28, plus pipeline updates. Highlights:

DMTTF

Citigroup Maintains Neutral on Rocket Companies, Raises Price Target to $8

Related Posts

Frequency Electronics, Inc. Names Tom McClelland As Permanent President And CEO

Short Seller Bear Cave Hits ODDITY Tech With Bear Report – What’s Going On?

Where Mineralys Therapeutics Stands With Analysts

Small Pharma Implements Cost-Cutting Strategy To Reduce Cash Burn As Trial Progresses